DNA methylation of HOXD3 as a marker of prostate cancer progression
Laboratory Investigation, 03/22/2010
Kron KJ et al. - The results indicate that HOXD3 methylation distinguishes low–grade prostate cancers from intermediate and high–grade ones and may also have prognostic value when considered together with pathological stage.







